GLP-1 promoter mediated insulin expression for the treatment of diabetes.
Insulin gene therapy is one of many envisioned alternative treatments of diabetes. Diabetes gene therapy would be possible if insulin could be produced in a regulated and specifically in a sensitive manner dependent on the blood glucose level.Therefore, the present invention relates to a method for...
Saved in:
Main Authors: | Ahmad, Zalinah, Omar, Abdul Rahman, Rasouli, Mina |
---|---|
Format: | Patent |
Language: | English |
Published: |
2010
|
Online Access: | http://psasir.upm.edu.my/id/eprint/32198/1/US20140112895A1.pdf http://psasir.upm.edu.my/id/eprint/32198/ https://patents.google.com/patent/US20140112895A1/en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of GIP and GLP-1 promoter-mediated insulin expression in Gut K and L-cells for the potential treatment of diabetes mellitus
by: Rasouli, Mina
Published: (2012) -
Engineering an L-cell line that expresses insulin under the control of the glucagon-like peptide-1 promoter for diabetes treatment
by: Rasouli, Mina, et al.
Published: (2011) -
Delivery of recombinant plasmid containing human insulin gene-GLP1 promoter into L cells in the rats with a type-1 diabetes
by: Eshkoor, Sima Ataollahi, et al.
Published: (2016) -
Beneficial effects of parenteral GLP-1 delivery by cell therapy in insulin-deficient streptozotocin diabetic mice.
by: Vasu, Srividya, et al.
Published: (2013) -
Insulin secreted from genetically engineered intestinal cells reduces blood glucose levels in diabetic mice
by: Rasouli, Mina, et al.
Published: (2013)